Target intelligence / Profile preview

Ribosomal protein L26 pseudogene 23 (RPL26P23)

Target
RPL26P23
Molecular classification
Other (Pseudogene)
01

Overview

The **ribosomal protein L26 pseudogene 23** (RPL26P23, ENSG00000234450) is a processed pseudogene found in the human genome and shares sequence similarity with the protein-coding gene for ribosomal protein L26. Pseudogenes such as RPL26P23 arise from duplication or retrotransposition of functional ribosomal protein genes but have acquired disabling mutations (such as stop codons or frameshifts) that prevent them from producing active protein[2][4][6][9][10]. These elements are typically scattered throughout the genome and do not encode functional proteins; instead, they may serve as genomic fossils or, rarely, sources for regulatory RNAs. RPL26P23 is not associated with any known disease processes or therapeutic targeting. **Key facts:** - RPL26P23 does not code for a functional protein. - It is a member of the large family of ribosomal protein pseudogenes in the human genome, specifically related to the RPL26 ribosomal protein[6]. - It is not a therapeutic target and has no known role in disease, drug binding, or cellular pathways[2][9][10]. - This entry should not be used when seeking actionable drug targets or functional molecular entities. If a functional ribosomal protein L26-like entity is required, the relevant gene is **RPL26L1 (Ribosomal protein L26 like 1)**, which is a protein-coding gene and not a pseudogene[5][7].

Other names
RPL26_13_865Ribosomal protein L26 pseudogene 23RPL26P23

Beyond the preview

Go deeper on Ribosomal protein L26 pseudogene 23 (RPL26P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L26 pseudogene 23 (RPL26P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call